$PAB next stop 0.021 resistance
Cheap MC, Patent secured today, volume in with buyers stepping up. Re-rating. BIOSHARE mentioned that PAB could be takeover before clinical trials due to interest in this technology. As always DYOR
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。